- Home
- SFHG vs SER Comparison
SFHG vs SER Comparison
Compare SFHG & SER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SFHG | SER |
|---|---|---|
| Founded | 1993 | 2017 |
| Country | Hong Kong | United States |
| Employees | N/A | 13 |
| Industry | Publishing | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.2M | 19.4M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | SFHG | SER |
|---|---|---|
| Price | $2.70 | $1.50 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $13.00 |
| AVG Volume (30 Days) | 78.5K | ★ 118.9K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $134.46 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.32 | $1.53 |
| 52 Week High | $3.17 | $7.92 |
Technical Indicators
Market Signals| Indicator | SFHG | SER |
|---|---|---|
| Relative Strength Index (RSI) | 81.93 | 32.92 |
| Support Level | $0.59 | N/A |
| Resistance Level | $3.17 | $1.86 |
| Average True Range (ATR) | 0.15 | 0.14 |
| MACD | 0.22 | 0.01 |
| Stochastic Oscillator | 80.57 | 4.71 |
Price Performance
Historical ComparisonAbout SFHG Samfine Creation Holdings Group Limited Ordinary Share
Samfine Creation Holdings Group Ltd operates through its subsidiaries. It is an established one-stop printing service provider which principally provides printing services in Hong Kong and the PRC. It offers a wide range of printed products such as (i) book products, which mainly include children's books, educational books, art books, notebooks, diaries and journals; and (ii) novelty and packaging products, which mainly include handcraft products, book sets, pop-up books, stationery products, products with assembly parts and other specialized products, shopping bags and package boxes.
About SER Serina Therapeutics Inc.
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.